| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1037989B1 Nucleotide and protein sequence of mammastatin and methods of use |
| 06/13/2007 | EP1037909B1 Postweaning multisystemic wasting syndrome virus from pigs |
| 06/13/2007 | EP0954330B1 Intestinal trefoil proteins |
| 06/13/2007 | EP0862630B1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 06/13/2007 | EP0792278B1 Tumor necrosis factor-gamma |
| 06/13/2007 | EP0742902B2 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
| 06/13/2007 | CN1981054A Methods for treating cancer using anti-WNT2 monoclonal antibodies and sirna |
| 06/13/2007 | CN1981049A Truncated adamts molecules |
| 06/13/2007 | CN1981034A Acetyl CoA carboxylase splice variant and uses thereof |
| 06/13/2007 | CN1981032A A novel strain of sars-associated coronavirus and use thereof |
| 06/13/2007 | CN1980958A Specific binding members against synaptophysin |
| 06/13/2007 | CN1980957A Receptor coupling agents and therapeutic uses thereof |
| 06/13/2007 | CN1980956A Humanized antibody against S-surface antigen of hepatitis b virus |
| 06/13/2007 | CN1980697A Preventing autoimmune disease by using anti-CD20 antibody |
| 06/13/2007 | CN1980696A Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients |
| 06/13/2007 | CN1980649A Methods and reagents for the treatment of immunoinflammatory disorders |
| 06/13/2007 | CN1978653A Human hlipase gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978649A Liver F protein prokaryotic expression product, and its preparing method and application for medical laboratory |
| 06/13/2007 | CN1978648A Human hNRBF2 gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978647A Human hN027 gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978646A Human hNmrr gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978645A Human hNIF3 s gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978644A Human hNGT gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978643A Human hMSC gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978642A Human hLDP gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978634A Avianinflu virus H5 subtype emulsion agglutination kit and its use |
| 06/13/2007 | CN1978465A Method for preparing heart fatty acid binding protein monoclonal antibody and its use |
| 06/13/2007 | CN1978456A Human hNit3-ase gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978455A Human hNDS4-iso gene sequence, and its coded protein and preparation method |
| 06/12/2007 | US7230087 P. aeruginosa mucoid exopolysaccharide specific binding peptides |
| 06/12/2007 | US7230086 Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices |
| 06/12/2007 | US7230085 Anti-DOTA antibody |
| 06/12/2007 | US7230084 Therapeutic using a bispecific antibody |
| 06/12/2007 | US7230083 Genetic engineered vitronectin receptors; restenosis therapy, anticancer agents |
| 06/12/2007 | US7230082 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 06/12/2007 | US7230078 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide |
| 06/12/2007 | US7230075 Coccidiosis poultry vaccine |
| 06/12/2007 | US7230073 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering |
| 06/12/2007 | US7229968 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 06/12/2007 | US7229962 A fusion protein is dimerized with two soluble extracellular domains of proteins by intermolecular disulfide bonds, formation/s-s/; improved stability and therapeutic effects |
| 06/12/2007 | US7229841 Expression vector for use treatment of cancer |
| 06/12/2007 | US7229822 Melanoma differentation associated gene-5 and vectors and cells containing same |
| 06/12/2007 | US7229782 Immunogens used to produce the antibodies |
| 06/12/2007 | US7229781 Diagnostic kit for predicting the onset of menopause |
| 06/12/2007 | US7229780 Monoclonal antibody against ovarian carcinoma |
| 06/12/2007 | US7229770 YKL-40 as a marker and prognostic indicator for cancers |
| 06/12/2007 | US7229628 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/12/2007 | US7229622 Synthetic chimeric fimbrin peptides |
| 06/12/2007 | US7229619 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 06/12/2007 | US7229618 complex of Synagis light chain and N-terminal fragment of Synagis heavy chain; precipitated with polyethylene glycol from propanol solution; for screening for, identifying and/or designing compounds that bind and/or modulate a biological activity of respiratory syncytial virus |
| 06/12/2007 | US7229617 An isolated cell that expresses an antibody binding to DR4 or DR5, two members of the tumor necrosis factor (TNF) receptor super family |
| 06/12/2007 | CA2319699C Placental protein 13 |
| 06/12/2007 | CA2300913C Novel compound 2-amino-3-[2-(.alpha.-mannopyranosyl)indol-3-yl]propionic acid, process for preparing the same, and method for inspecting function of living body with the novel compound |
| 06/12/2007 | CA2215834C Dna encoding human papillomavirus type 18 |
| 06/12/2007 | CA2198251C Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
| 06/12/2007 | CA2148252C Interaction trap system for isolating novel proteins |
| 06/12/2007 | CA2113712C Papilloma virus vaccine |
| 06/12/2007 | CA2072620C Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 06/12/2007 | CA2046649C Matrix metalloproteinase inhibitor peptides |
| 06/07/2007 | WO2007065151A2 Differential immunoassay for prrs vaccine antibody |
| 06/07/2007 | WO2007065037A2 Antibodies against mmp-13 (collagenase-3) and uses thereof |
| 06/07/2007 | WO2007064972A2 Monoclonal antibodies against amyloid beta protein and uses thereof |
| 06/07/2007 | WO2007064911A1 Anti-mouse cd20 antibodies and uses thereof |
| 06/07/2007 | WO2007064281A1 Hydrophobic interaction chromatography |
| 06/07/2007 | WO2007063903A1 Novel peptide compound |
| 06/07/2007 | WO2007063825A1 Monoclonal antibody directed against cd166 and method for production thereof |
| 06/07/2007 | WO2007063664A1 Vascular aging-predicting factor and utilization of the same |
| 06/07/2007 | WO2007063311A2 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | WO2007063308A2 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | WO2007062867A1 Microginin producing proteins and nucleic acids encoding a microginin gene cluster as well as methods for creating microginins |
| 06/07/2007 | WO2007062852A2 ANTI-Aβ GLOBULOMER ANTIBODIES, ANTIGEN-BINDING MOIETIES THEREOF, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCING SAID ANTIBODIES, COMPOSITIONS COMPRISING SAID ANTIBODIES, USES OF SAID ANTIBODIES AND METHODS OF USING SAID ANTIBODIES |
| 06/07/2007 | WO2007062466A1 Demibodies: dimerisation-activated therapeutic agents |
| 06/07/2007 | WO2007048127A9 Fc labeling for immunostaining and immunotargeting |
| 06/07/2007 | WO2007041317A3 Immunomodulatory compositions and uses therefor |
| 06/07/2007 | WO2007031550A3 Method for preparing immunoglobulin libraries |
| 06/07/2007 | WO2007025977A3 Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis |
| 06/07/2007 | WO2007025760A3 Melanoma-associated mhc class i associated oligopeptides and the uses thereof |
| 06/07/2007 | WO2007024846A3 Anit-il-23 antibiodies |
| 06/07/2007 | WO2007002359A3 Methods for identifying delta subunit-containing gaba receptor modulatory agents |
| 06/07/2007 | WO2006138315A3 Anti-igf1r antibody formulations |
| 06/07/2007 | WO2006137106A3 Method for the potentiation of opioid analgesics effects on pain |
| 06/07/2007 | WO2006128063A3 Methods and compositions for inhibiting glioma growth |
| 06/07/2007 | WO2006058202A3 Mer diagnostic and therapeutic agents |
| 06/07/2007 | WO2006002058A3 Treatment of autism |
| 06/07/2007 | WO2005060457A3 Treatment of inflammatory bowel diseases with anti-ip-10 antibodies |
| 06/07/2007 | WO2005058937A3 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 |
| 06/07/2007 | WO2005011619A3 Lung-expressed polypeptides |
| 06/07/2007 | WO2004110369A3 Cell surface protein associated with human chronic lymphocytic leukemia |
| 06/07/2007 | WO2004063214A3 Antibodies that specifically recognize sumo-conjugated proteins |
| 06/07/2007 | US20070130628 Method for producing immortalised antibodies-secreting cells |
| 06/07/2007 | US20070129538 Cytokine protein family |
| 06/07/2007 | US20070129324 Mammalian MDM2 binding proteins and uses thereof |
| 06/07/2007 | US20070129322 Recombinant protective protein from Streptococcus pneumoniae |
| 06/07/2007 | US20070129319 Genes encoding human deubiquitinating enzymes |
| 06/07/2007 | US20070128721 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 06/07/2007 | US20070128703 An immobilized acceptor having at least two sugar units is contacted with Pasteurella multocida transferases selected from pmHAS, pmCS, pmHS, PglA, in a reaction medium with a sugar precursor selected from uridine diphosphate (UDP)-glucosamine, UDP-N-acetylglucosamine, or UDP-N-acetylgalactosamine |
| 06/07/2007 | US20070128701 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 06/07/2007 | US20070128695 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |